AllDocs -> cancers

30 Mitch Dowsett PhD (left) Mitch Dowsett is Professor of Biochemical Endocrinology and Section Chairman of the Academic Department of Biochemistry at The Institute of Cancer Research. He is also Co-Team Leader for Molecular Endocrinology, a joint team between the Academic Department of Biochemistry and the Breakthrough Toby Robins Breast Cancer Research Centre at The Institute of Cancer Research Ian Smith MD FRCPE FRCP (right) Ian Smith is Professor of Cancer Medicine and Head of the Breast Unit at The Royal Marsden NHS Foundation Trust Improvements in breast cancer treatment Over 40,000 women develop breast cancer in the UK annually and the number continues to rise each year. Encouragingly, however, the death rate has been falling steadily over the last ten years. ...

What you need to know about BreastCancer Page 2 What is Breast Cancer ? Breast cancer is the most common cancer to affect women in the UK. Age: the older you are the greater your risk. Most breast cancers occur in women over 50 years old, it is extremely rare in women under 30. Menarche and Menopause: women who go through puberty at an early age or through the menopause at a later age have an increased risk. Having Children: women who have more children and have children at a younger age have a lower risk of breast cancer . Lifestyle Factors: being overweight, heavy alcohol consumption and smoking increase a woman’s risk of breast cancer . Hereditary Factors: women with a family history of breast cancer are at a higher ...

Breast Cancer Breast Cancer A GUIDE FOR PEOPLE WITH CANCER ,THEIR FAMILIES AND FRIENDS A GUIDE FOR PEOPLE WITH CANCER ,THEIR FAMILIES AND FRIENDS Telephone 13 11 20 for cancer information and support Page 2 Cancer information in other languages Breast cancer First published June 1993 This edition May 2004 Acknowledgments The Cancer Council thanks everyone who contributed to the development and revision of this booklet. Illustration on page 6 by Con Stamatis. Many Cancer Council services, including the publication of this booklet, would not be possible without the generous support of many Victorians. Leading the fight against cancer 1 Rathdowne Street Carlton Vic 3053 Australia Cancer Helpline: 13 11 20 Telephone: ...

Join the UFT and NYSUT in the Battle Against Breast Cancer Sunday, Oct.15, 2006 • 9:00 a.m. Servia Silva, UFT Chairperson This fall, the UFT will walk with other NYSUT locals throughout the state to raise funds for breast cancer research, advocacy and patient services. UFT teams will carry the banner in Central Park and four other borough locations. To register for “MAKING STRIDES AGAINST BREAST CANCER ” send coupon below to the UFT Office in the Borough where you want to walk, ATT: Making Strides Borough Coordinator. PLEASE PRINT Name Home Address __ E-Mail __ City __ State __ Zip _ Home Phone ( ) _ School Address __ District Borough _ I want to walk with the UFT Team in: s s Central ...

Princess Margaret Hospital launches revamped breast cancer centre FOR IMMEDIATE RELEASE Toronto, Aug. 30, 2006 – Many of the thousands of walkers who have raised $31 million for Princess Margaret Hospital (PMH) by participating in The Weekend to End Breast Cancer (WEBC) fundraising walks are about to get a sneak peek at the impact of their phenomenal success. The first-ever Breast Cancer Forum and Impact Tour takes place Wednesday, Aug. 30 from 6-9 p.m. at PMH when the hospital officially opens its revamped M. Lau Breast Centre. This is where walkers will see their dollars at work most visibly as they tour the newly unified hub for breast cancer care that now integrates and streamlines prevention, treatment and survivor programs. “It’s monumental to see the tangible results of the efforts – physical and fundraising – of so many dedicated people who are committed to our cause to ...

K a n s s R ve r M is ou ri R iver Missouri Kansas Conveniently Located The University of Kansas Hospital is located one mile south of Interstate 35 at 39th and Rainbow Boulevard in Kansas City, Kan., and is easily accessible from both sides of the state line. KU MedWest is located off Interstate 435 at Midland Drive and Renner Road in Shawnee, Kan. Breast Center at KU MedWest The Breast Center at KU MedWest offers mammography services for your regular screening mammograms. If the diagnosis is cancer , the Breast Center is backed by the expertise of the nationally recognized, board-certified specialists at The University of Kansas Hospital. Second Opinion Service If you have been diagnosed with breast cancer , we can provide you with a second opinion.Asking for a ...

breast cancer Breast Cancer Care Job Description Job Title Corporate Business Development and Sponsorship Manager Section: Corporate team (within Fundraising and Marketing Department) Location: The post is based at our central office in Putney (with relocation to Central London in summer 2007) Salary: Grade G, points 40-42 - £34,755 - £36,417 per annum inc. LW Contract: Permanent Accountable to: Head of Fundraising Responsible for: Corporate Business Development Executives x 2 Hours: 35 per week – generally 9.00am to 5.00pm About Breast Cancer Care: Breast Cancer Care is the leading provider of breast cancer information and support ...

breast cancer Breast Cancer Recurrence Fact Sheet Breast cancer is the second leading cause of cancer death for women in the United States. Every three minutes a woman in the U.S. is diagnosed with breast cancer ; one person dies of the disease every 14 minutes. Breast cancer accounts for one of three cancer diagnoses (excluding skin cancer ) for women in the U.S. New treatments and improved early-detection methods have led to an increase in the number of women who consider themselves a breast cancer survivor. There are more than two million survivors of breast cancer in the U.S. While advances in breast cancer treatment have increased the likelihood of survival, many breast cancer patients still may experience a recurrence of their disease. Options exist to reduce recurrence, but communication between patients ...

OPTIONS IN MANAGING EARLY BREAST CANCER Early breast cancer diagnosis Primary systemic therapy to shrink the tumor prior to surgery Early breast cancer (EBC) is cancer localized to breast tissue and/or nearby lymph nodes 1 Diagnosis is verified via excision/biopsy of the tumor 2 Radiation and/or chemotherapy are frequently used to improve local and systemic tumor control 7 This is usually followed by hormonal drug treatment in women with hormone-sensitive cancer 7 National Comprehensive Cancer Network (NCCN) guidelines recommend that aromatase inhibitors be part of the optimal adjuvant treatment of postmenopausal women with hormone-sensitive breast cancer 8 Tumor(s) removed by lumpectomy or mastectomy 5 Can include removal of ...

The 360 Group • California Breast Cancer Research Program Lead Scientist • Position Description • Page 1 of 4 303 Sacramento Street, Fourth Floor San Francisco, CA 94111 415.692.5243 www.360searchgroup.com POSITION DESCRIPTION August 21, 2006 Organization California Breast Cancer Research Program Location Oakland, CA Position Title Lead Scientist Reports to Director, CBCRP The Opportunity The California Breast Cancer Research Program (CBCRP) is the nation’s largest state-funded breast cancer research program and the fourth largest breast cancer research funder in the world. The CBCRP was founded in 1993 when breast cancer activists, scientists, clinicians, state legislators, and University of California officials collaborated to win passage of the California Breast Cancer ...

Office use only ck $_ D_ cc Cash R __ data lt __ # _ D_ __ __ __ Payment Information Cash - Checks Payable & Mail to: Cougar Club - Cougar Classic 66 George Street Charleston, SC 29424 Credit Card: Exp _ $ __ (Visa or MasterCard only) Signature Join the Lowcountry Affiliate of The Susan G. Komen Breast Cancer Foundation & The Cougar Classic Golf Tournament “ Raise Awareness for Breast Cancer ” Balloon Ceremony Yeamans Hall Club Hanahan, SC September 11, 2006 8:15 AM Help support the fight against breast cancer along with the Lowcountry Affiliate of the Susan G. Komen Breast Cancer Foundation and the Cougar Classic Golf Tournament. Together we hope to bring awareness through detection, prevention, and education to the young women participating in the ...

Breast screening The NHS breast screening programme was set up in 1988 with the aim of reducing the death toll from breast cancer . It now screens over one and a half million women each year.All women between the ages of 50 and 70 are invited for a free breast examination, using mammography, every three years. Thanks to screening and improved treatment, deaths from breast cancer have fallen dramatically. About breast cancer • More than 100 women in the UK are diagnosed with breast cancer every day. • It is the second most common cause of cancer death in UK women, after lung cancer . • The good news is that more women than ever are surviving the disease as a result of earlier detection and improved treatment. • Men can also develop breast cancer , but this is rare.There are around 300 cases in the UK each year.* Breast ...

Breast cancer (non-metastatic) Search date February 2004 J Michael Dixon, Alan Rodger, and Justin Stebbing What are the effects of interventions after breast conserving surgery for ductal carcinoma in situ? LIKELY TO BE BENEFICIAL Radiotherapy (reduced recurrence) Two RCTs identified by a systematic review found that radiotherapy after breast conserving surgery for ductal carcinoma in situ reduced local recurrence and invasive carcinoma compared with no radiotherapy after 4 and 8 years. However, they found no evidence of an effect on survival. One RCT in women having local excision found no significant difference between tamoxifen plus radiotherapy and radiotherapy alone in total invasive or ductal carcinoma in situ events after median follow up of 1 year. Tamoxifen plus radiotherapy (reduced recurrence in women with oestrogen receptor positive tumours) One RCT ...

Breast Cancer Facts Q: What is Breast Cancer ? A: Breast Cancer is the abnormal growth of breast cells, which may develop rapidly or over the course of many years. The cause is not yet known. Q: At what age do I need to worry about getting breast Cancer ? A: The disease can occur in women as early as age 20, and even earlier in rare cases. As women age, their chance of getting Breast Cancer steadily increases. Over 75% of women who are diagnosed with Breast Cancer are age 50 or older. Q: Is Breast Cancer only seen in white women? A: No. Any woman can get Breast Cancer ---and even some men. It is true that more Caucasian women develop Breast Cancer . However, more African American and Hispanic women die from Breast Cancer . This may be due to limited use of preventive services, resulting in late diagnosis and treatment. ...

Professor Gilberto Schwartsmann is Director of the South-American Office for Anticancer Drug Development (SOAD). He is also Professor of Oncology at the Postgraduate Course in Medicine, Federal University, and Director of the Cancer Center of the Lutheran University, Porto Alegre, Brazil. From 1989 to 1992, Professor Schwartsmann was Director of the European Organisation for Research and Treatment of Cancer (EORTC) New Drug Development Office. He completed a Fellowship in Oncology at the Middlesex Hospital & University College and Royal Marsden Hospital in London, UK (1981–1983). Professor Swartsmann obtained his PhD in Experimental Oncology at the Department of Medical Oncology of the Free University in Amsterdam, The Netherlands (1985–1988). He graduated from the Faculty of Medicine (1973–1979) and received his degree in Internal ...

SPECIAL COFFEE BLEND HONORS FALLEN HERO IN THE FIGHT AGAINST BREAST CANCER MINNEAPOLIS (April 18, 2006) – Anyone who says corporate America doesn’t have a heart hasn’t met the employees of Caribou Coffee Company. When a beloved roastmaster of Caribou Coffee died in 1995 of breast cancer at just 33 years of age, the Caribou employees didn’t just make contributions to breast cancer in her name. Instead, they have kept her memory alive for more than a decade by creating a special coffee named Amy’s Blend on sale each spring with proceeds going to the National Breast Cancer Foundation Inc. “A company isn’t an amorphous machine that makes and sells products; a company is made of people with a mission who all have hearts,” said Caribou Coffee CEO Michael Coles. “Through programs like this, we are able to show compassion not only for one of our own, but for all those throughout the nation who are ...

Fox Chase Cancer Center 2005 Scientific Report 1 Monica Morrow, M.D., Senior Member, Chairman of Surgical Oncology, G. Willing “Wing” Pepper Chair in Cancer Research Michael H.Torosian, M.D., Member, Clinical Director of Breast Surgery Research, Program Director of Surgical Oncology Fellowship John P. Hoffman, M.D., Senior Member, Attending Surgeon Elin R. Sigurdson, M.D., Ph.D., Senior Member, Attending Surgeon Lydia Giles, R.N., Study Coordinator Mary O’Brien, Medical Secretary Collaborating Researchers : Jose Russo, M.D., Senior Member, Department of Pathology Gary M. Freedman, M.D., Member, Department of Radiation Oncology Lori J. Goldstein, M.D., Member, Department of Medical Oncology Irma Russo, M.D., Member, Department of Pathology Penny R. Anderson, M.D., Associate Member, Department of Radiation Oncology ...

Fox Chase Cancer Center 2005 Scientific Report 1 Lori J. Goldstein, M.D., Member, Director, Breast Evaluation Center, Leader, Breast Cancer Research Program Mary B. Daly, M.D., Ph.D, Senior Member, Senior Vice President, Population Science, Director, Cancer Prevention & Control Program, Timothy R.Talbot Jr. Chair in Cancer Research V. Craig Jordan, O.B.E, Ph.D., D.Sc., Senior Member, Vice President and Scientific Director for Medical Science, Alfred G. Knudson Jr. Chair in Cancer Research Monica Morrow, M.D., F.A.C.S., Senior Member, Chairman, Surgical Oncology, G. Willing “Wing” Pepper Chair in Cancer Research Elin R. Sigurdson, M.D., Ph.D., Senior Member, Chief, Surgical Oncology Clinical Research Sharon L. Manne, Ph.D., Senior Member Suzanne M. Miller, Ph.D., ...

Influence of Known Breast Cancer Risk Factors on Breast Cancer Incidence Patterns in California Erdmann CA. Department of Epidemiology, University of Michigan School of Public Health Background: The San Francisco Bay Area reports some of the highest breast cancer incidence in the world. Within this region, breast cancer incidence is consistently high in Marin County. Average annual age-adjusted incidence 1998-2002 for invasive breast cancer incidence for Non-Hispanic White women in Marin County was 174/100,000 (2000 U.S. population standard). One possible explanation for the high breast cancer incidence in Marin County is that known breast cancer risk factors are more prevalent in Marin County than in areas of lower incidence. Objective: To estimate the proportion of breast cancer cases that could be avoided if known breast cancer risk factors were eliminated ...

Copyright 2006 American Society of Clinical Oncology and National Comprehensive Cancer Network. All rights reserved. No part of these measures may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without written permission by ASCO and NCCN. Breast Cancer Measures 1. IF a patient with stage I-III breast cancer meets all of the following criteria: 1) ER+ and/or PR+ breast cancer 2) Tumor size > 1 cm THEN the patient should be given tamoxifen or aromatase inhibitor (AI) within 1 year after diagnosis Numerator Denominator Exclusions Data Elements Notes Patient received tamoxifen or AI within 1 year after diagnosis • Patient diagnosed with stage I (> 1 cm), stage II, or stage III ...

4 | Visit our Web site at www.evergreenhealthcare.org Visit our Web site at www.evergreenhealthcare.org | 5 Lung Cancer Lung cancer is a particularly nasty opponent. Due in large part to late detection, the survival rate for patients is only about 12 percent. WarnInG sIGns Lung cancer often does not cause symptoms for many years. As a result, lung cancer is frequently discovered only when physicians are screening patients for other conditions. Symptoms may include: • A persistent cough • Chest pain • Hoarseness • Weight loss and loss of appetite • Spit or phlegm that is bloody or rust-colored • Shortness of breath • Repeated bouts of pneumonia or bronchitis If you have any of these symptoms, talk to a doctor immediately. rIsK faCTors • Ninety percent of lung cancers occur in people who smoke. The more a person ...

SCREENING FOR BREAST CANCER IN ENGLAND: PASTAND FUTURE Advisory Committee on Breast Cancer Screening* NHSBSP Publication No 61 February 2006 * Members of the Advisory Committee on Breast Cancer Screening : Professor V Beral (Chairman), Ms S Cush, Professor IO Ellis, Dr J Emery, Dr K Faulkner, Dr R Given-Wilson, Professor M Law, Ms J Loughlin, Dr MJ Michell, Dr SM Moss, Ms M Noblet, Mrs J Patnick, Professor M Reed, Dr C Rubin, Mrs K Toward, Ms D Winstone. * Members of the Advisory Committee’s subcommittees contributing to this report : Dr J Austoker, Professor V Beral (Chairman), Dr A Berrington, Dr RG Blanks, Professor NE Day, Ms TJ Day, Professor IO Ellis, Dr K Faulkner, Professor H Møller, Dr SM Moss, Mrs J Patnick (Secretary), Dr M Quinn, Dr MG Wallis, Dr ARM Wilson. Page 2 Published by: NHS Cancer Screening Programmes Fulwood ...

158 S. Stanwood Rd Columbus, OH 43208 (800) 337-9288 desaction@columbus.rr.com NEW GROUP OF WOMEN IDENTIFIED WITH INCREASED BREAST CANCER RISK A new group of women has been identified as having an increased risk for breast cancer . According to a study led by Julie R. Palmer of Boston University’s Slone Epidemiology Center, women who were exposed before birth to the anti-miscarriage drug diethylstilbestrol (DES) are nearly two times more likely to develop breast cancer , after age 40 than unexposed women. The study was published in the scientific journal, Cancer Epidemiology Biomarkers and Prevention . DES is a synthetic estrogen that was prescribed to millions of pregnant women in the U.S. primarily from 1938-1971. Its use was thought to prevent miscarriage and ensure a healthy pregnancy. Since then it has been linked to reproductive cancers, infertility, and ...

http://www.komen.org/stellent/fragments/ccdetailview/detailview.asp?cc_id=37776 DES Daughters at Increased Risk of Breast Cancer August 8, 2006 According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention , women exposed to diethylstilbestrol (DES) before birth have an increased risk of developing breast cancer after the age of 40. Diethylstilbestrol is a synthetic estrogen that was used frequently in pregnant women between the 1940s and 1960s. The drug was used to reduce the risk of miscarriages, though later studies indicated that it most likely had no effect on miscarriage risk. In 1971 a study reported that girls born to women who had used DES (DES daughters) had a greatly increased risk of developing a certain type of vaginal cancer . The risk of breast cancer in these daughters is also of interest for two reasons: 1) DES has been found to increase ...

• Breast cancer has no boundaries and it doesn’t discriminate. In fact, 85% of all women diagnosed with breast cancer DO NOT have a family history. • While the overall breast cancer mortality rate has steadily declined over the past decade, the mortality rate for minority women has not declined at the same pace. • Breast cancer is the leading cause of cancer death among Latina women in Oregon. • The reason for the higher mortality rates in Latino & African-American populations is a combination of access, awareness and cultural pressures that might not allow for open discussion about breasts. It takes real money to overcome these barriers. • Among Latinas, breast cancer is more frequently diagnosed at a later stage when fewer treatment options are available. • A recent study revealed that when Caucasian, African-American and Latina women were provided equal ...

By Fern Carness, MPH, RN T here are countless, misleading myths regarding the nature of breast cancer . For the sake of your health it’s important to know the difference between myth and reality. Below are some of the common breast cancer myths, as well as a dose of reality to help set the record straight. Myth vs. Reality MYTH: Mammograms are 100 percent accurate. REALITY: Few things in life are 100 percent accurate; the same is true for mammograms. If you have a normal mammogram, but still feel a lump, insist on further follow-up. MYTH: You’re not at risk for breast cancer if you don’t have a family history. REALITY: More than 80 percent of newly diagnosed breast cancers are found in women with NO family history. Regular screenings are important for women of all ages. MYTH: Breast cancer is an older woman’s ...

FACTS ABOUT BREAST CANCER Breast cancer is the most common type of cancer in American women, according to the American Cancer Society. This year, nearly 213,000 women and 1,700 men will learn they have breast cancer . Another 62,000 women will learn they have nonin- vasive (also called in situ) breast cancer . Nearly 41,000 women and 500 men will die from breast cancer this year. Breast cancer can often be cured. About 80 percent of all patients with breast cancer are free of the disease 10 years after their diagnosis. RADIATION THERAPY for BREAST CANCER Understanding Your Treatment Options THE AMERICAN SOCIETY FOR THERAPEUTIC RADIOLOGY AND ONCOLOGY Targeting Cancer Care 8280 Willow Oaks Corporate Drive Suite 500 Fairfax, VA 22031 Phone: 1-800-962-7876 • 703-502-1550 ...

Breast Cancer Disparities Research Program (previously Population Specific Research) Request for Application (RFA) Guidelines Background. The Susan G. Komen Breast Cancer Foundation is one of the nation's largest private funding sources for breast health and breast cancer research. Our mission is to eradicate breast cancer as a life- threatening disease by advancing research, education, screening and treatment. Only projects supportive of the Komen mission will be considered. Particular consideration will be given to projects that are innovative, non-duplicative of other efforts and have the potential to seed continuing study. This program offers a maximum funding award of $300,000 for a two or three year period. Application guidelines and instructions are included in this announcement. Purpose. The purpose of this program is to foster or continue investigations examining the disparities ...

Embargo date: 2 nd August 2006, 09.00am Help us to find out more about preventing breast cancer , say researchers Researchers from the Withington Hospital, South Manchester University Hospitals Trust, announced today that 100 women from the area have joined a pioneering breast cancer prevention study but that many more are still needed. The study called IBIS-2 is supported by Cancer Research UK and has been ongoing in Manchester and throughout the UK since 2004. IBIS-2 is the first worldwide study to investigate whether a breast cancer treatment drug called anastrozole can prevent the disease in postmenopausal women who are at higher risk of the disease. Previous research on anastrozole as a treatment for early stage breast cancer suggested that anastrozole might prevent 70-80% of hormone-receptor positive tumours in women at high risk of breast cancer . But ...

V V V i i i s s s i i i t t t o o o u u u r r r w w w e e e b b b s s s i i i t t t e e e f f f o o o r r r m m m o o o r r r e e e i i i n n n f f f o o o r r r m m m a a a t t t i i i o o o n n n o o o r r r o o o n n n l l l i i i n n n e e e o o o r r r d d d e e e r r r i i i n n n g g g : : : w w w w w w w w w . i i i o o o s ...